Advertisement

Infectious disease specialist explains what may have halted AstraZeneca vaccine trial

Dr. Sumon Chakrabarti says a condition called transverse myelitis may have been the adverse reaction that forced AstraZeneca to pause a trial of a coronavirus vaccine.